img

Global Peptide Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Peptide Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
Peptide Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Peptide Vaccine market is projected to reach US$ 4935.8 million in 2029, increasing from US$ 3683 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2029. Demand from Prostate Cancer and Breast Cancer are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptide Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Segment by Type
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)

Segment by Application


Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Peptide Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Peptide Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Peptide Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Peptide Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Peptide Vaccine introduction, etc. Peptide Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Peptide Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Peptide Vaccine Market Overview
1.1 Peptide Vaccine Product Overview
1.2 Peptide Vaccine Market Segment by Type
1.2.1 Solution Phase Synthesis (SPS)
1.2.2 Solid Phase Peptide Synthesis (SPPS)
1.3 Global Peptide Vaccine Market Size by Type
1.3.1 Global Peptide Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Peptide Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Peptide Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Peptide Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Peptide Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Peptide Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Peptide Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Peptide Vaccine Sales Breakdown by Type (2018-2024)
2 Global Peptide Vaccine Market Competition by Company
2.1 Global Top Players by Peptide Vaccine Sales (2018-2024)
2.2 Global Top Players by Peptide Vaccine Revenue (2018-2024)
2.3 Global Top Players by Peptide Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Peptide Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Peptide Vaccine Market Competitive Situation and Trends
2.5.1 Peptide Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Peptide Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Peptide Vaccine Market
2.8 Key Manufacturers Peptide Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Peptide Vaccine Status and Outlook by Region
3.1 Global Peptide Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Peptide Vaccine Historic Market Size by Region
3.2.1 Global Peptide Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Peptide Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Peptide Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Peptide Vaccine Forecasted Market Size by Region
3.3.1 Global Peptide Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Peptide Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Peptide Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Peptide Vaccine by Application
4.1 Peptide Vaccine Market Segment by Application
4.1.1 Prostate Cancer
4.1.2 Breast Cancer
4.1.3 Gastric Cancer
4.1.4 Lung Cancer
4.1.5 Pancreatic Cancer
4.1.6 Others
4.2 Global Peptide Vaccine Market Size by Application
4.2.1 Global Peptide Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Peptide Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Peptide Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Peptide Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Peptide Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Peptide Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Peptide Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Peptide Vaccine Sales Breakdown by Application (2018-2024)
5 North America Peptide Vaccine by Country
5.1 North America Peptide Vaccine Historic Market Size by Country
5.1.1 North America Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Peptide Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Peptide Vaccine Sales in Value by Country (2018-2024)
5.2 North America Peptide Vaccine Forecasted Market Size by Country
5.2.1 North America Peptide Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Peptide Vaccine Sales in Value by Country (2024-2029)
6 Europe Peptide Vaccine by Country
6.1 Europe Peptide Vaccine Historic Market Size by Country
6.1.1 Europe Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Peptide Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Peptide Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Peptide Vaccine Forecasted Market Size by Country
6.2.1 Europe Peptide Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Peptide Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Peptide Vaccine by Region
7.1 Asia-Pacific Peptide Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Peptide Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Peptide Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Peptide Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Peptide Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Peptide Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Peptide Vaccine Sales in Value by Region (2024-2029)
8 Latin America Peptide Vaccine by Country
8.1 Latin America Peptide Vaccine Historic Market Size by Country
8.1.1 Latin America Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Peptide Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Peptide Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Peptide Vaccine Forecasted Market Size by Country
8.2.1 Latin America Peptide Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Peptide Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Peptide Vaccine by Country
9.1 Middle East and Africa Peptide Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Peptide Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Peptide Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Peptide Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Peptide Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Peptide Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Anergis
10.1.1 Anergis Company Information
10.1.2 Anergis Introduction and Business Overview
10.1.3 Anergis Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Anergis Peptide Vaccine Products Offered
10.1.5 Anergis Recent Development
10.2 Antigen Express
10.2.1 Antigen Express Company Information
10.2.2 Antigen Express Introduction and Business Overview
10.2.3 Antigen Express Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Antigen Express Peptide Vaccine Products Offered
10.2.5 Antigen Express Recent Development
10.3 Apitope Technology
10.3.1 Apitope Technology Company Information
10.3.2 Apitope Technology Introduction and Business Overview
10.3.3 Apitope Technology Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Apitope Technology Peptide Vaccine Products Offered
10.3.5 Apitope Technology Recent Development
10.4 Artificial Cell Technologies
10.4.1 Artificial Cell Technologies Company Information
10.4.2 Artificial Cell Technologies Introduction and Business Overview
10.4.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Artificial Cell Technologies Peptide Vaccine Products Offered
10.4.5 Artificial Cell Technologies Recent Development
10.5 Benovus Bio
10.5.1 Benovus Bio Company Information
10.5.2 Benovus Bio Introduction and Business Overview
10.5.3 Benovus Bio Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Benovus Bio Peptide Vaccine Products Offered
10.5.5 Benovus Bio Recent Development
10.6 Celgene Corporation
10.6.1 Celgene Corporation Company Information
10.6.2 Celgene Corporation Introduction and Business Overview
10.6.3 Celgene Corporation Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Celgene Corporation Peptide Vaccine Products Offered
10.6.5 Celgene Corporation Recent Development
10.7 Immatics biotechnologies
10.7.1 Immatics biotechnologies Company Information
10.7.2 Immatics biotechnologies Introduction and Business Overview
10.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Immatics biotechnologies Peptide Vaccine Products Offered
10.7.5 Immatics biotechnologies Recent Development
10.8 Merck
10.8.1 Merck Company Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Merck Peptide Vaccine Products Offered
10.8.5 Merck Recent Development
10.9 ImmunoCellular Therapeutics
10.9.1 ImmunoCellular Therapeutics Company Information
10.9.2 ImmunoCellular Therapeutics Introduction and Business Overview
10.9.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 ImmunoCellular Therapeutics Peptide Vaccine Products Offered
10.9.5 ImmunoCellular Therapeutics Recent Development
10.10 ISA Pharmaceuticals
10.10.1 ISA Pharmaceuticals Company Information
10.10.2 ISA Pharmaceuticals Introduction and Business Overview
10.10.3 ISA Pharmaceuticals Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 ISA Pharmaceuticals Peptide Vaccine Products Offered
10.10.5 ISA Pharmaceuticals Recent Development
10.11 Lytix Biopharma
10.11.1 Lytix Biopharma Company Information
10.11.2 Lytix Biopharma Introduction and Business Overview
10.11.3 Lytix Biopharma Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Lytix Biopharma Peptide Vaccine Products Offered
10.11.5 Lytix Biopharma Recent Development
10.12 Spotlight Innovation
10.12.1 Spotlight Innovation Company Information
10.12.2 Spotlight Innovation Introduction and Business Overview
10.12.3 Spotlight Innovation Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Spotlight Innovation Peptide Vaccine Products Offered
10.12.5 Spotlight Innovation Recent Development
10.13 OncoTherapy Science
10.13.1 OncoTherapy Science Company Information
10.13.2 OncoTherapy Science Introduction and Business Overview
10.13.3 OncoTherapy Science Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 OncoTherapy Science Peptide Vaccine Products Offered
10.13.5 OncoTherapy Science Recent Development
10.14 Peptech
10.14.1 Peptech Company Information
10.14.2 Peptech Introduction and Business Overview
10.14.3 Peptech Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Peptech Peptide Vaccine Products Offered
10.14.5 Peptech Recent Development
10.15 Pharmasyntez
10.15.1 Pharmasyntez Company Information
10.15.2 Pharmasyntez Introduction and Business Overview
10.15.3 Pharmasyntez Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Pharmasyntez Peptide Vaccine Products Offered
10.15.5 Pharmasyntez Recent Development
10.16 Sumitomo Dainippon Pharma
10.16.1 Sumitomo Dainippon Pharma Company Information
10.16.2 Sumitomo Dainippon Pharma Introduction and Business Overview
10.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sumitomo Dainippon Pharma Peptide Vaccine Products Offered
10.16.5 Sumitomo Dainippon Pharma Recent Development
10.17 TapImmune
10.17.1 TapImmune Company Information
10.17.2 TapImmune Introduction and Business Overview
10.17.3 TapImmune Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.17.4 TapImmune Peptide Vaccine Products Offered
10.17.5 TapImmune Recent Development
10.18 Targovax
10.18.1 Targovax Company Information
10.18.2 Targovax Introduction and Business Overview
10.18.3 Targovax Peptide Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Targovax Peptide Vaccine Products Offered
10.18.5 Targovax Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Peptide Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Peptide Vaccine Industrial Chain Analysis
11.4 Peptide Vaccine Market Dynamics
11.4.1 Peptide Vaccine Industry Trends
11.4.2 Peptide Vaccine Market Drivers
11.4.3 Peptide Vaccine Market Challenges
11.4.4 Peptide Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Peptide Vaccine Distributors
12.3 Peptide Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Solution Phase Synthesis (SPS)
Table 2. Major Company of Solid Phase Peptide Synthesis (SPPS)
Table 3. Global Peptide Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Peptide Vaccine Sales by Type (2018-2024) & (K Dose)
Table 5. Global Peptide Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Peptide Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Peptide Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Peptide Vaccine Price by Type (2018-2024) & (US$/Dose)
Table 9. Global Peptide Vaccine Sales by Type (2024-2029) & (K Dose)
Table 10. Global Peptide Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Peptide Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Peptide Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Peptide Vaccine Price by Type (2024-2029) & (US$/Dose)
Table 14. North America Peptide Vaccine Sales by Type (2018-2024) & (K Dose)
Table 15. North America Peptide Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Peptide Vaccine Sales (K Dose) by Type (2018-2024)
Table 17. Europe Peptide Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Peptide Vaccine Sales (K Dose) by Type (2018-2024)
Table 19. Asia-Pacific Peptide Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Peptide Vaccine Sales (K Dose) by Type (2018-2024)
Table 21. Latin America Peptide Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Peptide Vaccine Sales (K Dose) by Type (2018-2024)
Table 23. Middle East and Africa Peptide Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Peptide Vaccine Sales by Company (2018-2024) & (K Dose)
Table 25. Global Peptide Vaccine Sales Share by Company (2018-2024)
Table 26. Global Peptide Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Peptide Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Peptide Vaccine Price by Company (2018-2024) & (US$/Dose)
Table 29. Global Peptide Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Peptide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Peptide Vaccine Market
Table 33. Key Manufacturers Peptide Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Peptide Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Peptide Vaccine Sales by Region (2018-2024) & (K Dose)
Table 37. Global Peptide Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Peptide Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Peptide Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 41. Global Peptide Vaccine Sales by Region (2024-2029) & (K Dose)
Table 42. Global Peptide Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Peptide Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Peptide Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Peptide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2024-2029)
Table 46. Global Peptide Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Peptide Vaccine Sales by Application (2018-2024) & (K Dose)
Table 48. Global Peptide Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Peptide Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Peptide Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Peptide Vaccine Price by Application (2018-2024) & (US$/Dose)
Table 52. Global Peptide Vaccine Sales by Application (2024-2029) & (K Dose)
Table 53. Global Peptide Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Peptide Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Peptide Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Peptide Vaccine Price by Application (2024-2029) & (US$/Dose)
Table 57. North America Peptide Vaccine Sales by Application (2018-2024) (K Dose)
Table 58. North America Peptide Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Peptide Vaccine Sales by Application (2018-2024) (K Dose)
Table 60. Europe Peptide Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Peptide Vaccine Sales by Application (2018-2024) (K Dose)
Table 62. Asia-Pacific Peptide Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Peptide Vaccine Sales by Application (2018-2024) (K Dose)
Table 64. Latin America Peptide Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Peptide Vaccine Sales by Application (2018-2024) (K Dose)
Table 66. Middle East and Africa Peptide Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 68. North America Peptide Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Peptide Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Peptide Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 72. North America Peptide Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Peptide Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Peptide Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 76. Europe Peptide Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Peptide Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Peptide Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 80. Europe Peptide Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Peptide Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Peptide Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Peptide Vaccine Sales by Region (2018-2024) & (K Dose)
Table 84. Asia-Pacific Peptide Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Peptide Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Peptide Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Peptide Vaccine Sales by Region (2024-2029) & (K Dose)
Table 88. Asia-Pacific Peptide Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Peptide Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Peptide Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 92. Latin America Peptide Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Peptide Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Peptide Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 96. Latin America Peptide Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Peptide Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Peptide Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Peptide Vaccine Sales by Country (2018-2024) & (K Dose)
Table 100. Middle East and Africa Peptide Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Peptide Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Peptide Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Peptide Vaccine Sales by Country (2024-2029) & (K Dose)
Table 104. Middle East and Africa Peptide Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Peptide Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Peptide Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Anergis Company Information
Table 108. Anergis Introduction and Business Overview
Table 109. Anergis Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 110. Anergis Peptide Vaccine Product
Table 111. Anergis Recent Development
Table 112. Antigen Express Company Information
Table 113. Antigen Express Introduction and Business Overview
Table 114. Antigen Express Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 115. Antigen Express Peptide Vaccine Product
Table 116. Antigen Express Recent Development
Table 117. Apitope Technology Company Information
Table 118. Apitope Technology Introduction and Business Overview
Table 119. Apitope Technology Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 120. Apitope Technology Peptide Vaccine Product
Table 121. Apitope Technology Recent Development
Table 122. Artificial Cell Technologies Company Information
Table 123. Artificial Cell Technologies Introduction and Business Overview
Table 124. Artificial Cell Technologies Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 125. Artificial Cell Technologies Peptide Vaccine Product
Table 126. Artificial Cell Technologies Recent Development
Table 127. Benovus Bio Company Information
Table 128. Benovus Bio Introduction and Business Overview
Table 129. Benovus Bio Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 130. Benovus Bio Peptide Vaccine Product
Table 131. Benovus Bio Recent Development
Table 132. Celgene Corporation Company Information
Table 133. Celgene Corporation Introduction and Business Overview
Table 134. Celgene Corporation Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 135. Celgene Corporation Peptide Vaccine Product
Table 136. Celgene Corporation Recent Development
Table 137. Immatics biotechnologies Company Information
Table 138. Immatics biotechnologies Introduction and Business Overview
Table 139. Immatics biotechnologies Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 140. Immatics biotechnologies Peptide Vaccine Product
Table 141. Immatics biotechnologies Recent Development
Table 142. Merck Company Information
Table 143. Merck Introduction and Business Overview
Table 144. Merck Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 145. Merck Peptide Vaccine Product
Table 146. Merck Recent Development
Table 147. ImmunoCellular Therapeutics Company Information
Table 148. ImmunoCellular Therapeutics Introduction and Business Overview
Table 149. ImmunoCellular Therapeutics Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 150. ImmunoCellular Therapeutics Peptide Vaccine Product
Table 151. ImmunoCellular Therapeutics Recent Development
Table 152. ISA Pharmaceuticals Company Information
Table 153. ISA Pharmaceuticals Introduction and Business Overview
Table 154. ISA Pharmaceuticals Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 155. ISA Pharmaceuticals Peptide Vaccine Product
Table 156. ISA Pharmaceuticals Recent Development
Table 157. Lytix Biopharma Company Information
Table 158. Lytix Biopharma Introduction and Business Overview
Table 159. Lytix Biopharma Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 160. Lytix Biopharma Peptide Vaccine Product
Table 161. Lytix Biopharma Recent Development
Table 162. Spotlight Innovation Company Information
Table 163. Spotlight Innovation Introduction and Business Overview
Table 164. Spotlight Innovation Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 165. Spotlight Innovation Peptide Vaccine Product
Table 166. Spotlight Innovation Recent Development
Table 167. OncoTherapy Science Company Information
Table 168. OncoTherapy Science Introduction and Business Overview
Table 169. OncoTherapy Science Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 170. OncoTherapy Science Peptide Vaccine Product
Table 171. OncoTherapy Science Recent Development
Table 172. Peptech Company Information
Table 173. Peptech Introduction and Business Overview
Table 174. Peptech Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 175. Peptech Peptide Vaccine Product
Table 176. Peptech Recent Development
Table 177. Pharmasyntez Company Information
Table 178. Pharmasyntez Introduction and Business Overview
Table 179. Pharmasyntez Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 180. Pharmasyntez Peptide Vaccine Product
Table 181. Pharmasyntez Recent Development
Table 182. Sumitomo Dainippon Pharma Company Information
Table 183. Sumitomo Dainippon Pharma Introduction and Business Overview
Table 184. Sumitomo Dainippon Pharma Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 185. Sumitomo Dainippon Pharma Peptide Vaccine Product
Table 186. Sumitomo Dainippon Pharma Recent Development
Table 187. TapImmune Company Information
Table 188. TapImmune Introduction and Business Overview
Table 189. TapImmune Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 190. TapImmune Peptide Vaccine Product
Table 191. TapImmune Recent Development
Table 192. Targovax Company Information
Table 193. Targovax Introduction and Business Overview
Table 194. Targovax Peptide Vaccine Sales (K Dose), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2018-2024)
Table 195. Targovax Peptide Vaccine Product
Table 196. Targovax Recent Development
Table 197. Key Raw Materials Lists
Table 198. Raw Materials Key Suppliers Lists
Table 199. Peptide Vaccine Market Trends
Table 200. Peptide Vaccine Market Drivers
Table 201. Peptide Vaccine Market Challenges
Table 202. Peptide Vaccine Market Restraints
Table 203. Peptide Vaccine Distributors List
Table 204. Peptide Vaccine Downstream Customers
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Vaccine Product Picture
Figure 2. Global Peptide Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Peptide Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Peptide Vaccine Sales Status and Outlook (2018-2029) & (K Dose)
Figure 5. Product Picture of Solution Phase Synthesis (SPS)
Figure 6. Global Solution Phase Synthesis (SPS) Sales YoY Growth (2018-2029) & (K Dose)
Figure 7. Product Picture of Solid Phase Peptide Synthesis (SPPS)
Figure 8. Global Solid Phase Peptide Synthesis (SPPS) Sales YoY Growth (2018-2029) & (K Dose)
Figure 9. Global Peptide Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Peptide Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Peptide Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Peptide Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Peptide Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Peptide Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Peptide Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Peptide Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Peptide Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Peptide Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Peptide Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Peptide Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptide Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptide Vaccine Revenue in 2022
Figure 23. Peptide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Prostate Cancer
Figure 25. Global Prostate Cancer Sales YoY Growth (2018-2029) & (K Dose)
Figure 26. Product Picture of Breast Cancer
Figure 27. Global Breast Cancer Sales YoY Growth (2018-2029) & (K Dose)
Figure 28. Product Picture of Gastric Cancer
Figure 29. Global Gastric Cancer Sales YoY Growth (2018-2029) & (K Dose)
Figure 30. Product Picture of Lung Cancer
Figure 31. Global Lung Cancer Sales YoY Growth (2018-2029) & (K Dose)
Figure 32. Product Picture of Pancreatic Cancer
Figure 33. Global Pancreatic Cancer Sales YoY Growth (2018-2029) & (K Dose)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Dose)
Figure 36. Global Peptide Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Peptide Vaccine Sales Market Share by Application in 2022 & 2029
Figure 38. North America Peptide Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. North America Peptide Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Europe Peptide Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Europe Peptide Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Peptide Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Peptide Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Latin America Peptide Vaccine Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Peptide Vaccine Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Peptide Vaccine Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Peptide Vaccine Manufacturing Cost Structure
Figure 49. Peptide Vaccine Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries